RNRMarketResearch.com

The Global Vaccines Market is projected to grow at a CAGR of 8.3% by 2021

Press Release   •   Jan 20, 2017 01:59 EST

The global Vaccines Market is expected to reach USD 48.03 Billion by 2021 from USD 32.24 Billion in 2016 at a CAGR of 8.3% from 2016 to 2021.Browse 89 market data Tables and 55 Figures spread through 158 Pages and in-depth TOC on "Vaccines Market" http://www.rnrmarketresearch.com/vaccine-market-by-technology-types-trend-analysis-by-various-classes-live-attenuated-subunit-toxoid-conjugate-dna-recombinant-vector-synthetic-dentritic-vaccines-and-by-indications-i-market-report.html

The major factor driving the growth of this market are high prevalence of diseases, rising government and nongovernment funding for vaccine development, increasing investments by companies, and increasing focus on immunization programs.The conjugate vaccines segment is expected to register the highest growth rate in the vaccines market, by technology, during the forecast period. The high growth in this segment is attributed to the increasing company investments in development of new vaccines. Based on end-users, the vaccines market is segmented into paediatrics and adults. The pediatrics segment is expected to account for the largest share of the market in 2016. Increasing prevalence of diseases in children and the rising number of awareness programs to promote vaccination will drive the growth of this market.

Disease indication, included in the Vaccines Market are pneumococcal disease, influenza, diphtheria, tetanus, and pertussis (DTP), hepatitis, rotavirus, varicella, meningococcal disease, polio, measles, mumps, and rubella (MMR), human papilloma virus (HPV) infection, and others. The pneumococcal disease segment is expected to account for the largest share of the global Vaccines Market in 2016. High incidence of pneumococcal infections is driving the growth of this market. Geographically, the vaccines market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). Growth in the North American segment is primarily driven by rising government funding for vaccine research in the North American countries.

The major factors contributing to the growth of the vaccines market include high prevalence of diseases, rising government and nongovernment funding for vaccine development, and increasing focus on immunization programs. Furthermore, increasing R&D spending and new vaccine development activities by companies is another major factor driving the growth of this market.

Inquire about this report : http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=110437

Apart from comprehensive geographic and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise the product portfolios, developments, and strategies adopted by the market players to maintain and increase their shares in the market. The above-mentioned market research data, current market size, and forecast of the future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach and levels of output in order to remain successful in the market.

The major players in this market include Astellas Pharma Inc. (Japan), CSL Limited (Australia), Emergent BioSolutions, Inc. (U.S.), GlaxoSmithKline, plc. (U.K.), Johnson & Johnson (U.S.), MedImmune, LLC (U.S.), Merck & Co. (U.S.), Pfizer, Inc. (U.S.), Sanofi Pasteur (France), and Serum Institute of India Pvt. Ltd. (India).

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the vaccines market. The report analyses the vaccines market by technology, type, disease indication, end-users, and regions
  • Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and new product launches in the vaccines market
  • Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the vaccines market
  • Market Development: Comprehensive information about emerging markets. This report analyses the market for various vaccines across geographies
  • Market Diversification: Exhaustive information about new vaccines, untapped geographies, recent developments, and investments in the vaccines market

Now Get Sample Copy of this report at http://www.rnrmarketresearch.com/contacts/request-sample?rname=110437

Gists of Table of Content

Premium Insights on following: Global Vaccines Market,Vaccines Market, By Type, Geographic Analysis: Market, By End User, Geographic Analysis: Market, By Technology, Geographical Snapshot of the Market, Lifecycle Analysis, By Region, 2016

Market Overview on following , Market Segmentation, Market Dynamics, Drivers, High Prevalence of Diseases, Rising Government and Non-Government Funding for Vaccine Development, Increasing Investments By Companies, Increasing Government Focus on Immunization Programs, Restraints, Huge Capital Investments, Stringent Regulations Opportunities, High Growth Prospects in Emerging Markets, Therapeutic Vaccines, Adjuvant Vaccines, Challenges, Inadequate Access to Vaccines, Vaccine Pricing, Burning Issues Vaccine Failure, Investment Analysis

Vaccines Market, By Technology: Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Recombinant Vaccines

Vaccines Market, By Type on the basis of Monovalent Vaccines Multivalent Vaccines

Vaccines Market, By Disease Indication: Pneumococcal Disease, DTP, Influenza, Human Papilloma Virus, Meningococcal Disease, Polio, Rotavirus, Hepatitis, MMR, Varicella and Others

Vaccines Market, By End User Pediatrics and Adults

Vaccines Market, By Region; North America, U.S., Canada, Europe, Germany, U.K., France, Italy, Spain, Rest of Europe (RoE), Asia, Japan, China, India, Rest of Asia and Rest of the World

Competitive Landscape, Market Share Analysis, Competitive Situation and Trends, Agreements, Collaborations, and Partnerships, Regulatory Approvals, Acquisitions, Expansions
Other Developments

Browse Related Reports:

Veterinary / Animal Vaccines Market by Product (Livestock, Companion, Poultry, Equine, Porcine), Diseases (Rabies, Distemper, Foot & Mouth, Gumboro, Swine& Avian Influenza, Strangles) & Technology (Live attenuated, DNA, Inactivated) - Global Forecast to 2020. This report provides insights on the following pointers: Market Penetration, Product Development/Innovation, Competitive Assessment, Market Development, Market Diversification, Now Get Sample Copy of this report at http://www.rnrmarketresearch.com/contacts/request-sample?rname=391556

Vaccine Adjuvants Marketby Product Type (Particulate, Emulsions, Pathogen, Saponin), Route of Administration (Subcutaneous, Intramuscular), Disease Type (Infectious, Cancer), Application (Research, Commercial) & Application Category - Forecasts to 2021. The report projects The vaccine adjuvants market to reach USD 769.4 million by 2021 growing at a CAGR of 10.5%. Now Get Sample Copy of this report at : http://www.rnrmarketresearch.com/contacts/request-sample?rname=615761

Rnrmarketresearch.com is your single source for all market research needs. Our database includes 100,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

RnR Market Research

Corporate Headquarters
2nd floor, metropole,
Next to inox theatre,
Bund garden road, Pune-411001.
+ 1 888 391 5441